跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEVOFLOXACIN IN 5% DEXTROSE INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LEVOFLOXACIN IN 5% DEXTROSE INJECTION
Authorized
STANDARD
LEVOFLOXACIN IN 5% DEXTROSE INJECTION
hikma canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
86254d4eb429348e
Company
hikma canada limited
Type
Standard
Approval Details
Approval Id
86254d4eb429348e
Drug Approval Canada Name
LEVOFLOXACIN IN 5% DEXTROSE INJECTION
Product Name
LEVOFLOXACIN IN 5% DEXTROSE INJECTION
Status
Marketed
Status Date
2023-10-23
Original Market Date
2023-10-23
Din
02537079
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:12.18
Atc Original
J01MA12 LEVOFLOXACIN
Atc Name
j 01 ma 12
Aig Number
0131663001
Company Name
hikma canada limited
Company Address
5995 Avebury Road, Suite 804, Mississauga, Ontario, Canada, L5R 3P9
Active Ingredients
LEVOFLOXACIN
5 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
86254d4eb429348e
Type
Standard
Back to Health Canada Approvals